Medicines planning
47 results
Applied filters
Preparing to use natalizumab biosimilar
6 February 2024Natalizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team.
Understanding patents
11 July 2025Patents allow the inventor a finite period of monopoly in exchange for publicising the idea. We explain how they work with respect to medicines.
Primary care discussions: biosimilar insulin
30 September 2025Discussion about the considerations of implementing biosimilar insulin in primary care. Hints and tips for systems considering a move to biosimilar insulin.
The licence and supporting evidence for aflibercept biosimilars
4 February 2026Aflibercept 2mg biosimilars are available for NHS use. Learn about supporting evidence and differences.
Preparing to use denosumab 60mg biosimilar
16 January 2026Biosimilars of denosumab 60mg (Prolia) are available. We offer general information and implementation advice.
The licence and supporting evidence for denosumab 60mg biosimilars
24 April 2026Denosumab 60mg biosimilars are licensed. Learn about indications, formulations, supporting evidence and differences.
National Homecare Medicines Committee (NHMC) Homecare Service Proposal (HSP) Form
25 November 2021Find and download the NHMC Homecare Service Proposal form.
National Homecare Medicines Committee (NHMC) Terms of Reference
5 April 2018Find attached the terms of reference for the NHMC subgroups
National Homecare Medicines Committee (NHMC) homecare digital strategy
4 August 2020Find attached the NHMC homecare digital strategy
National Homecare Medicines Committee (NHMC) Engagement with Manufacturers Advice
4 August 2020Explanation of engagement with the National Homecare Medicines Committee for manufacturers